Literature DB >> 14583860

Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy.

Moe H Kyaw1, Peter Christie, Stuart C Clarke, John D Mooney, Syed Ahmed, Ian G Jones, Harry Campbell.   

Abstract

A record linkage study was done to provide comprehensive data on the epidemiologic characteristics of invasive pneumococcal disease (IPD) in Scotland. The overall incidence of IPD was 11 cases/10(5) persons and 21 cases/10(5) persons <1 year of age, 51 cases/10(5) persons 1 year of age, 45 cases/10(5) elderly persons (age > or =65 years), 176-483 cases/10(5) persons with chronic medical conditions, and 562-2031 cases/10(5) persons with severe immunosuppression. The case-fatality rate was 11% among elderly persons and ranged from 3% to 13% among persons with underlying medical conditions. The most common pneumococcal serogroups associated with IPD were 14, 9, 6, 19, 23, 8, and 4. Serogroups included in the 23-valent polysaccharide vaccine caused the majority of cases of IPD. The proportion of IPD due to the 7-, 9-, and 11-valent conjugate vaccine serogroups was lower among older people and persons with underlying medical conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14583860     DOI: 10.1086/379016

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Serotypes and sequence types of pneumococci causing invasive disease in Scotland prior to the introduction of pneumococcal conjugate polysaccharide vaccines.

Authors:  S C Clarke; K J Scott; S M McChlery
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004.

Authors:  Andreas Kronenberg; Phillip Zucs; Sara Droz; Kathrin Mühlemann
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

Authors:  Lea-Ann S Kirkham; Johanna M C Jefferies; Alison R Kerr; Yu Jing; Stuart C Clarke; Andrew Smith; Tim J Mitchell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: possible implications for UK vaccine policy.

Authors:  S M McChlery; K J Scott; S C Clarke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

5.  Burden of paediatric invasive pneumococcal disease in Europe, 2005.

Authors:  E D G McIntosh; B Fritzell; M A Fletcher
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

6.  Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in Scotland.

Authors:  Stuart C Clarke; Johanna M Jefferies; Andrew J Smith; Jim McMenamin; Timothy J Mitchell; Giles F S Edwards
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

7.  Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.

Authors:  J M Jefferies; A J Smith; G F S Edwards; J McMenamin; T J Mitchell; S C Clarke
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

8.  Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection.

Authors:  Youssif Mohammed Ali; Azam Hayat; Bayad Mawlood Saeed; Kashif S Haleem; Saleh Alshamrani; Hany I Kenawy; Viviana P Ferreira; Gurpanna Saggu; Anna Buchberger; Peter J Lachmann; Robert B Sim; Dimitrios Goundis; Peter W Andrew; Nicholas J Lynch; Wilhelm J Schwaeble
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

9.  Increase in Infant Measles Deaths During a Nationwide Measles Outbreak-Mongolia, 2015-2016.

Authors:  Christopher T Lee; Jose E Hagan; Baigalmaa Jantsansengee; Oyun-Erdene Tumurbaatar; Samdan Altanchimeg; Buyanjargal Yadamsuren; Sodbayar Demberelsuren; Chinbayar Tserendorj; Oyungerel Munkhtogoo; Darmaa Badarch; Nyamaa Gunregjav; Bolortuya Baatarkhuu; Chimedsuren Ochir; LaShondra Berman; Raydel Anderson; Minal K Patel; Christopher J Gregory; James L Goodson
Journal:  J Infect Dis       Date:  2019-10-22       Impact factor: 5.226

10.  Death or survival from invasive pneumococcal disease in Scotland: associations with serogroups and multilocus sequence types.

Authors:  Donald Inverarity; Karen Lamb; Mathew Diggle; Chris Robertson; David Greenhalgh; Tim J Mitchell; Andrew Smith; Johanna M C Jefferies; Stuart C Clarke; Jim McMenamin; Giles F S Edwards
Journal:  J Med Microbiol       Date:  2011-03-10       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.